- Home
- YMT vs GALT Comparison
YMT vs GALT Comparison
Compare YMT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMT
- GALT
- Stock Information
- Founded
- YMT 2011
- GALT 2000
- Country
- YMT China
- GALT United States
- Employees
- YMT N/A
- GALT N/A
- Industry
- YMT EDP Services
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- YMT Technology
- GALT Health Care
- Exchange
- YMT Nasdaq
- GALT Nasdaq
- Market Cap
- YMT 263.1M
- GALT 232.3M
- IPO Year
- YMT 2025
- GALT N/A
- Fundamental
- Price
- YMT $1.79
- GALT $4.75
- Analyst Decision
- YMT
- GALT Strong Buy
- Analyst Count
- YMT 0
- GALT 3
- Target Price
- YMT N/A
- GALT $6.00
- AVG Volume (30 Days)
- YMT 84.5K
- GALT 367.3K
- Earning Date
- YMT 01-01-0001
- GALT 11-12-2025
- Dividend Yield
- YMT N/A
- GALT N/A
- EPS Growth
- YMT N/A
- GALT N/A
- EPS
- YMT N/A
- GALT N/A
- Revenue
- YMT $21,547,440.00
- GALT N/A
- Revenue This Year
- YMT N/A
- GALT N/A
- Revenue Next Year
- YMT N/A
- GALT N/A
- P/E Ratio
- YMT N/A
- GALT N/A
- Revenue Growth
- YMT 19.68
- GALT N/A
- 52 Week Low
- YMT $1.70
- GALT $0.73
- 52 Week High
- YMT $6.05
- GALT $6.55
- Technical
- Relative Strength Index (RSI)
- YMT N/A
- GALT 60.29
- Support Level
- YMT N/A
- GALT $4.10
- Resistance Level
- YMT N/A
- GALT $5.06
- Average True Range (ATR)
- YMT 0.00
- GALT 0.29
- MACD
- YMT 0.00
- GALT -0.05
- Stochastic Oscillator
- YMT 0.00
- GALT 56.25
About YMT Yimutian Inc. American Depositary Shares
Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.